University Hospital of Wales
Immunodeficiency Center for Wales
Stephen Jolles is a consultant clinical immunologist and honorary professor at the University Hospital of Wales and Noah's Ark Children’s Hospital for Wales, as well as clinical lead at the Immunodeficiency Centre of Wales. Professor Jolles trained in immunology and allergy at the Royal Free Hospital and Great Ormond Street Hospital in London, the John Radcliffe in Oxford and Westmead Hospital in Sydney. He obtained his PhD on Langerhans cell migration in the lab of Dr Ann Ager at the National Institute for Medical Research, London, in 2002. His current research interests include the clinical use of immunoglobulins, the development of new screening strategies to improve the laboratory diagnosis of primary and secondary immunodeficiencies and allergies, and the establishment of better approaches for monitoring immunodeficiencies and the impact of associated treatments.

Moderator of 1 Session

Session Type
Industry Supported Sessions
Date
Wed, 12.10.2022
Session Time
15:35 - 17:05
Room
Plenary Hall
Session Description
New insights into immune system disorders – what does this mean for managing primary and secondary immunodeficiency? - Symposium is Organised and Supported by CSL Behring

Session Description

This CSL Behring-sponsored symposium, led by prominent experts in immunology and haem-oncology, will deliver insights into our evolving understanding of primary immunodeficiency (PID) and secondary immunodeficiency (SID). Sessions will focus on the importance of immune-microbe interactions in immune system disorders, the blurred lines between PID and SID, the risk of SID-associated infections in haematological malignancies and how personalised therapy may be appropriately delivered for patients with immunodeficiencies. These sessions will also identify important unmet needs in immune system disorders and discuss how these may be addressed to optimise patient care.

Presenter of 3 Presentations

Applying our understanding to personalised therapy in primary and secondary immunodeficiency

Session Type
Industry Supported Sessions
Date
Wed, 12.10.2022
Session Time
15:35 - 17:05
Room
Plenary Hall
Lecture Time
16:35 - 16:55

Discussion and Audience Q&A

Session Type
Industry Supported Sessions
Date
Wed, 12.10.2022
Session Time
15:35 - 17:05
Room
Plenary Hall
Lecture Time
16:55 - 17:05

Immunoglobulin replacement therapy

Session Type
IPOPI
Date
Fri, 14.10.2022
Session Time
14:15 - 15:45
Room
IPOPI Hall
Lecture Time
14:35 - 14:45